OSR Holdings buys VXM01 IP portfolio from Vaximm for $30 million

OSR Holdings

OSR Holdings

OSRH

0.00
  • OSR Holdings agreed to buy VXM01’s global intellectual property portfolio from Vaximm for USD 30 million.
  • Payment becomes due on the first milestone under OSRH’s BCME license: completion of a Phase 2 study in GBM or PDAC.
  • Assets include patents, manufacturing know-how, regulatory filings, clinical data, biological materials, and key program contracts.
  • Patent coverage spans major markets, with protection extending into 2038.
  • Deal follows an April 29, 2026 exclusive global VXM01 license with BCME that carries up to USD 815 million milestones.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OSR Holdings Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202605270906ACCESSWRNAPR_____1170935) on May 27, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.